OTCMKTS:CGNH CardioGenics (CGNH) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsBuy This Stock About CardioGenics Stock (OTCMKTS:CGNH) Get CardioGenics alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume37 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview CardioGenics Holdings, Inc. (OTCMKTS: CGNH) is a clinical diagnostics company specializing in the development, production and commercialization of immunoenzymatic assay kits and instruments for the detection and monitoring of cardiovascular disease. The company’s core focus lies in high-sensitivity cardiac biomarkers, which support early diagnosis of myocardial infarction, heart failure and related conditions. CardioGenics leverages proprietary antibody technology and assay platforms to deliver quantitative test results in clinical laboratory settings. Headquartered in the United States, CardioGenics serves healthcare providers and diagnostic laboratories globally through a combination of direct sales channels and distribution partners. Its product portfolio includes high-sensitivity troponin assays, D-dimer tests and additional biomarker panels, all of which have received regulatory approvals in multiple markets. The company continues to advance its pipeline with new assays targeting emerging cardiovascular risk factors and therapeutic monitoring applications. Since its founding in the early 2000s, CardioGenics has pursued strategic collaborations and licensing agreements to strengthen its technology platform and extend its geographic reach. The management team brings together expertise in molecular diagnostics, clinical chemistry and regulatory affairs, guiding efforts to optimize manufacturing processes and support clinical adoption of the company’s assays worldwide.AI Generated. May Contain Errors. Read More Receive CGNH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CardioGenics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CGNH Stock News HeadlinesCGNH CardioGenics Holdings IncAugust 28, 2024 | seekingalpha.comMagnetic Beads Market Size to Reach USD 6.7 Bn by 2032 with CAGR of 15.5% | TMR StudyApril 6, 2023 | benzinga.comYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.July 24 at 1:00 AM | Profits Run (Ad)Magnetic Beads Market Size, Share, Growth Statistics, Leading Players and Forecast 2028April 6, 2023 | marketwatch.com2023-2029 Global Cardiac Marker POC Analyzer Market Growth Analysis ReportMarch 29, 2023 | marketwatch.comThe Worldwide Cardiac Biomarkers Industry is Expected to Reach $23.8 Billion by 2027March 10, 2023 | finance.yahoo.comCardiogenics Holdings Inc (CGNH)January 16, 2022 | nasdaq.comUPDATED: CARDIOGENICS HOLDINGS INC. ANNOUNCES A RECORD DATE CHANGE FOR ITS DIVIDEND DISTRIBUTIONSeptember 28, 2021 | finance.yahoo.comSee More Headlines CGNH Stock Analysis - Frequently Asked Questions How do I buy shares of CardioGenics? Shares of CGNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of CardioGenics own? Based on aggregate information from My MarketBeat watchlists, some other companies that CardioGenics investors own include Trinity Biotech (TRIB), Samsung Electronics (SSNLF), Rock Creek Pharmaceuticals (RCPIQ), Merck & Co., Inc. (MRK), MediPharm Labs (MEDIF) and Labrador Iron Mines (LBRMF). Company Calendar Today7/24/2026Fiscal Year End10/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED INSTRUMENTS Sub-IndustryBusiness Services Current SymbolOTCMKTS:CGNH CIK1089029 Webwww.cardiogenics.com Phone(905) 673-8501Fax905-673-9865Employees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (OTCMKTS:CGNH) was last updated on 7/24/2026 by MarketBeat.com Staff. From Our PartnersThis tiny piece of glass could be bigger than GPUsJensen Huang says AI can't scale without it. Google Ventures calls it the future of AI compute. Sequoia Capita...Brownstone Research | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredElon says “don’t save money.” Is he right?Robert Kiyosaki, author of Rich Dad Poor Dad, says you don't have to wait for Elon Musk's vision of universal ...Freedom Financial | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredBofA: Digital Dollar Coming 2025-2030Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredWhat's the Best Way to Lower RMD Taxes?Once you turn 73, the IRS requires you to take distributions from your IRA, 401(k), and other retirement accou...SmartAsset | SponsoredThey’re still buying the wrong AI stocksTesla and Alphabet just tumbled, and many investors concluded AI is over. It isn't - the easy AI trade may be....The Oxford Club | SponsoredMy name is Dylan Jovine. Read this one.Bank CEOs summoned to Washington. Congressmen walking out of a sealed briefing. Central banks hoarding gold at...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CardioGenics Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CardioGenics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
